Zantac and B-lymphocyte count decreased - from FDA reports
There is no B-lymphocyte count decreased reported by people who take Zantac yet. This review analyzes which people have B-lymphocyte count decreased with Zantac. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Jul, 20, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have B-lymphocyte count decreased when taking Zantac?
- Check symptoms - is b-lymphocyte count decreased caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Join related support groups - you are not alone, join a support group on ehealth.me
- Report the side effect - help people in need and in real time
- More tools...
Zantac has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. (latest outcomes from Zantac 50,703 users)
B-lymphocyte Count Decreased
B-lymphocyte count decreased has been reported by people with rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, osteoporosis, idiopathic thrombocytopenic purpura (latest reports from 234 B-lymphocyte count decreased patients).